Remove Healthcare Remove Medical science Remove Medicine
article thumbnail

The Role of Medical Science Liaisons in The Pharmaceutical Industry

Contrarian Sales Techniques

Are you ready to explore the fascinating world of Medical Science Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals.

article thumbnail

Impact of Marketing Strategies in Healthcare Systems

Medico Reach

One of the essential parts of exponential growth in the healthcare emporium is effective marketing strategies. Furthermore, with the increment in the need for hospital beds, healthcare systems are in dire need of such approaches. Like any industry, a relevant marketing strategy can help healthcare practices rise effectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Precision Medicine Requires Opportunities to Connect with Patients

PM360

Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medical science can achieve. Accelerating the Path to Diagnosis and Treatment. However, this bustling space also faces some unique challenges. A company interested in Marc’s disease should talk to Marc.

article thumbnail

Pharmaceutical Companies Also Made the Fortune 500 List

Medico Reach

They aim to transform healthcare and create a healthier world. It developed the COVID vaccine Comirnaty and received FDA approval for TicoVac and Prevnar 20. The organization aims to develop life-altering medicines across various therapeutic domains. COV2, cancer drug Darzalex, and an anti-inflammatory medicine Stelara .

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7

Patients 105
article thumbnail

Recurrent drug shortages signal onerous outlook for cardiovascular care

Pharmaceutical Technology

Cardiovascular medicines were ranked as the sixth most affected drug class by shortages, as per a 2019 European Association of Hospital Pharmacists (EAHP) survey, says the organisation’s director of finance, Nenad Miljkovi?. These] are life-saving medications. “We’ve already been consistently experiencing them.

Medicine 111
article thumbnail

Dapagliflozin approved for heart failure across LVEFs

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency ( MHRA ) has granted a licence extension for FORXIGA (dapagliflozin) in Great Britain for symptomatic chronic heart failure (HF) across the full spectrum of left ventricular ejection fraction (LVEF).